Abstract
Twenty-four male Wistar rats, 8 weeks old, were allocated into three groups and treated with human recombinant epidermal growth factor (EGF) administered subcutancously in doses of 0, 30, and 150 μg/kg per day for 4 weeks. Blood sampling was done every 2nd week and urine sampling was done for 2 consecutive days every week. The most striking finding was that the ureters were dose dependently enlarged, due to growth of all layers of the ureteric wall. The urothelium of the bladder showed considerable hyperplasticity with a widening of the basal proliferative compartment and a normal differentiation pattern as observed by the expression of carbohydrate epitopes, characterized with lectinohistochemistry. Blood examination revealed a decrease in blood haemoglobin concentration and a slight increase in serum creatinine concentration in the high-dose group. There were no effects of EGF on the urinary excretion of electrolytes, proteins, and endogenous EGF.
Similar content being viewed by others
References
Coimbra TM, Cieslinski DA, Humes HD (1990) Epidermal growth factor accelerates renal repair in mercuric chloride nephrotoxicity. Am J Physiol 259:F438
Coon JS, Weinstein RS, Summars JL (1982) Blood group precursor T-antigen expression in human urinary bladder carcinoma. Am J Clin Pathol 77:692
Frystyk J, Vinter-Jensen L, Skjærbæk C, Flyvbjerg A (1995) The effect of epidermal growth factor on circulating levels of free and total IGF-1 and IGF-binding proteins in adult rats. Growth Regn (in press)
Goodlad RA, Wilson TJ, Lenton W, Gregory H, McCullagh KG, Wright NA (1987) Thtravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats. Gut 28:573
Gow CB, Phillips PA, Chandler KD, Moore GP (1993) Hormonal, fluid, and electrolyte responses of sheep during chronic intravenous infusion of epidermal growth factor. Am J Physiol 265:R203
Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sørensen FB, Vesterby A, West MJ (1988) Some new, simple and efficient stereclogical methods and their use in pathological research and diagnosis. APMIS 96:379
Harris RC, Daniel TO (1989) Epidermal growth factor binding, stimulation of phosphorylation, and inhibition of gluconeogenesis in rat proximal tubule. J Cell Physiol 139:383
Harris RC, Hoover RL, Jacobson HR, Badr KF (1988) Evidence for glomerular actions of epidermal growth factor in the rat J Clin Invest 82:1028
Jørgensen PE, Rasmussen TN, Skov Olsen P, Raaberg L, Seier Poulsen S, Nexø E (1990) Renal uptake and excretion of epidermal growth factor from plasma in the rat. Regul Pept 28:273
Jørgensen PE, Hilchey SD, Nexø E, Poulsen SS, Quilley CP (1993) Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma. J Endocrinol 139:227
Juhl CO, Vinter-Jensen L, Myhre-Jensen O, Jensen LS, Dajani EZ (1995) Systemic treatment with epidermal growth factor induces anaemia in Goettingen minipigs. Clin Sci 89:453
Kissmeyer Nielsen P, Vinter-Jensen L, Smerup M (1995) Growth and morphology of the rat colon following EGF treatment, Gut (in press)
Langkilde NC, Hastrup J, Olsen S, Wolf H, Ørntoft TF (1989) Immunohistochemistry and cytochemistry of experimental rat bladder cancer: binding of the lectins PNA and WGA and of a Ley mouse monoclonal antibody. J Urol 141:981
Langkilde NC, Wolf H, Clausen H, Ørntoft T (1992) Localization and identification of T-(Galβ1-3GalNacα1-O-R) and T-like antigens in experimental rat bladder cancer. J Urol 148:1279
Lotan R, Skutelsky E, Danon E, Sharon N (1975) The purification, composition and specificity of the anti-T lectin from peanuts (Arachis hypogeae). J Biol Chem 250:8518
Matsumoto I, Osawa T (1969) Purification and characterization of an anti-H(O) phytohemagglutinin of Ulex europaeus. Biochim Biophys Acta 194:180
Messing EM, Hanson P, Ulrich P, Erturk E (1987) Epidermal growth factor — interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol 138:1329
Møller JC, Djurhuus JC (1994) Obstructive disease of the kidney (hydronephrosis) and the urinary tract. In Craig Tisher C, Brenner BM (eds) Renal pathology: with clinical and functional correlations. J.B. Lippincott, Philadelphia, p 863
Nagata Y, Burger MM (1974) Wheat germ agglutinin. Molecular characteristics and specificity for sugar binding. J Clin Invest 249:3116
Neal DE, Mellon K (1992) Epidermal growth factor receptor and bladder cancer: a review. Urol Int 48:365
Neal DE, Charlton RG, Bennet MK (1987) Histochemical study of lectin binding in neoplastic and non-neoplastic urothelium. Br J Urol 60:399
Nexø E, Jørgensen PE, Hansen MR (1992) Human epidermal growth factor-on molecular forms present in urine and blood, Regul Pept 42:75
Noguchi S, Yura Y, Sherwood ER, Kakinuma H, Kashihara N, Oyasu R (1990) Stimulation of stromal cell growth by normal rat urothelial cell-derived epidermal growth factor. Lab Invest 62:538
Norman J, Badie Dezfooly B, Nord EP, Kurtz I, Schlosser J, Chaudhari A, Fine LG (1987) EGF-induced mitogenesis in proximal tubular cells: potentiation by angiotensin II. Am J Physiol 253:F299
Norman J, Tsau YK, Bacay A, Fine LG (1990) Epidermal growth factor accelerates functional recovery from ischaemic acute tubular necrosis in the rat: role of the epidermal growth factor receptor. Clin Sci 78:445
Ørntoft TF (1994) Carbohydrate changes in bladder carcinomas (review). APMIS [Suppl 27] 100:181
Ørntoft TF, Wolf H, Clausen H, Hakomori S, Dabelsteen E (1987) Blood group ABO-related antigens in fetal and normal adult bladder urothelium. J Urol 138:171
Ørntoft TF, Wolf H, Clausen H, Hakomori S, Dabelsteen E (1988) Blood group ABO-related antigens in fetal and normal adult bladder urothelium: immunohistochemical study of type 2 chain structures with a panel of monoclonal antibodies. Lab Invest 58:576
Rall LB, Scott J, Bell GI, Crawford RJ, Penschow JD, Niall HD, Coghlan JP (1985) Mouse prepro-epidermal growth factor synthesis by the kidney and other tissues. Nature 313:228
Riden DJ, Kirby JD, Maizels M (1993) Expression of transforming growth factor beta and epidermal growth receptor mRNA in UPJ obstruction. Proceedings of the American Academy of Pediatrics, Abstract, p 62
Tollefsen SE, Kornfeldt R (1983) Isolation and characterization of lectins from Vicia villosa. J Biol Chem 258:5165
Vinter-Jensen L, Juhl CO, Djurhuus JC, Poulsen SS, Dajani EZ, Brown KD, Ørntoft TF, Teglbjærg PS, Nexø E (1995a) Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates. Am J Pathol 147:1330
Vinter-Jensen L, Smerup M, Kissmeyer-Nielsen P, Poulsen SS (1995b) Chronic systemic treatment with epidermal growth factor in the rat increases the mucosal surface of the small intestine. Regul Pept (in press)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vinter-Jensen, L., Smerup, M., Jørgensen, P.E. et al. Chronic treatment with epidermal growth factor stimulates growth of the urinary tract in the rat. Urol. Res. 24, 15–21 (1996). https://doi.org/10.1007/BF00296727
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00296727